Equinox Chair Leads $6.5m Financing Round For Vesalius Longevity Labs

Harvey Spevak is backing the publicly traded peptide and longevity company as it looks to expand its provider network and enter new markets

Vesalius Longevity Labs has raised $6.5 million in a financing round led by an investor group organized by Harvey Spevak, the chairman of luxury fitness and wellness giant Equinox Group.

The publicly traded longevity company, formerly known as Sweet Earth Holdings Corporation, completed a private placement of approximately 6.2 million units at $1.05 apiece, generating nearly $6.5 million in gross proceeds.

The funding will support Vesalius‘ plans to expand its sales team, enter new markets and grow its platform connecting licensed healthcare providers with peptide therapies and other longevity-focused offerings.

“I believe longevity represents one of the most exciting opportunities in health and wellness over the coming decade,” Spevak said. “Vesalius has an ambitious vision for building a differentiated platform. I’m excited to partner with the team and bring my experience in building consumer-focused brands, driving innovation and creating long-term value to help shape the company’s next phase of growth.”

Vesalius operates a provider-focused longevity platform spanning peptides, biologics, preventive healthcare and performance optimization. Its business model connects healthcare providers with telehealth infrastructure, product fulfillment and regenerative health offerings.

The investment also marks another move into the growing longevity sector for Spevak, who recently transitioned from CEO to chairman of Equinox Group as former Anheuser-Busch CEO Brendan Whitworth took over leadership of the luxury fitness company.

Under Spevak’s leadership, Equinox expanded beyond traditional fitness into a broader luxury wellness offering, including its high-end Optimize membership, which combines personal training, recovery services and health assessments. Last week, Equinox hired former Anheuser-Busch CEO Brendan Whitworth as its new CEO; Spevak is staying on as chairman.

Vesalius, which trades on the Canadian Securities Exchange under the ticker SE and plans to transition to VLAB, said the financing will help accelerate its international growth.

The transaction includes warrants allowing investors to purchase additional shares at $2.25 apiece over the next two years.

More from ATN

• Fitness Chains Are Now ‘Sought-After’ Retail Tenants, Report Says
• New Startups Push to Innovate Strength Training Tech
• ATHX Games Unveils USA vs Europe Competition
• Just Released: Athletech’s Gym of the Future Report
• Want the industry edge? Join ATN Pro for unlimited access, exclusive analysis and event perks.